TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
AMGN

Amgen Inc

Healthcare · Drug Manufacturers - General

379.80$ +0.9% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios AMGN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
Valuation
19.1 23.2 40.5 54.0 41.3 34.5 28.4 22.8 21.8 23.0 24.5 22.5
5.4 5.5 5.2 5.5 5.4 4.2 4.9 4.3 4.3 4.8 5.1 5.2
18.9 25.0 30.3 28.5 23.2 24.0 27.2 20.3 15.9 20.5 20.8 16.9
6.3 7.4 7.0 7.2 6.9 5.7 6.4 5.7 5.5 6.1 6.4 6.3
11.5 14.1 17.1 18.8 16.8 14.2 14.2 12.5 12.0 13.2 14.2 14.6
15.0 20.4 20.7 29.5 27.8 13.6 15.4 14.2 13.3 21.9 22.3 19.4
6.7% 4.9% 4.8% 3.4% 3.6% 7.4% 6.5% 7.0% 7.5% 4.6% 4.5% 5.2%
Margins
73.6% 70.0% 66.4% 63.3% 60.5% 61.5% 63.0% 64.5% 66.1% 70.5% 71.5% 72.7%
33.0% 28.0% 23.6% 20.0% 19.1% 21.7% 21.8% 23.4% 24.1% 28.0% 31.6% 33.2%
28.2% 23.8% 12.7% 10.1% 13.0% 12.2% 17.4% 19.0% 19.5% 21.0% 20.9% 22.9%
35.9% 27.0% 24.9% 18.5% 19.3% 31.1% 32.0% 30.4% 32.1% 22.0% 23.1% 26.7%
Returns
98.8% 107.8% 74.9% 52.8% 56.2% 69.6% 95.6% 89.1% 72.8% 89.1% 84.9% 74.8%
8.4% 6.9% 4.0% 3.4% 4.7% 4.5% 6.6% 7.5% 7.8% 8.5% 8.4% 9.1%
Balance Sheet & Debt
25,727 53,669 54,312 53,344 51,387 48,126 48,571 48,176 45,142 45,475 45,285 43,315
1.7 3.6 4.5 4.5 3.8 3.6 3.2 3.0 2.7 2.7 2.7 2.6
8.5% 6.4% 5.4% 6.5% 8.3% 6.4% 6.9% 8.5% 10.7% 9.6% 9.9% 12.2%
7.9 10.4 12.7 10.6 8.0 10.2 9.2 7.6 5.7 6.3 6.2 4.9
Per Share
14.06 12.44 7.02 5.79 7.80 7.55 10.97 12.23 12.92 14.20 14.34 16.07
49.88 52.20 55.10 57.18 60.03 61.67 63.08 64.52 66.35 67.71 68.45 70.08
14.23 11.54 9.37 10.95 13.89 10.84 11.47 13.73 17.75 15.94 16.89 21.49
17.89 14.09 13.71 10.59 11.59 19.18 20.18 19.60 21.29 14.92 15.80 18.70

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?